PNC Financial Services Group
IPCI

PNC Financial Services Group’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

PNC Financial Services Group’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-344
Closed -$7K – 4600
2016
Q1 		$7K Buy
+344
New +$7.65K ﹤0.01% 3729
2014
Q4 		– Sell
-1,200
Closed -$36K – 4312
2014
Q3 		$36K Buy
+1,200
New +$34.6K ﹤0.01% 2843

Other funds holding IPCI

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $8.94B AUM 20.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
ATC
Argent Trust Co Nashville, Tennessee $2.95B AUM 22.66% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

PNC Financial Services Group's IPCI Position: Q2 2016 in Review

PNC Financial Services Group sold out of Intellipharmaceuticals International Inc. (IPCI) in Q2 2016, closing a stake of 344 shares — an estimated $7K sold.

PNC Financial Services Group first reported a position in IPCI in Q3 2014 and held it in 2 quarters. The position peaked at $36K in Q3 2014. 18 funds tracked by Wall St. Rank hold IPCI as of Q2 2016.

  • PNC Financial Services Group reported no remaining Intellipharmaceuticals International Inc. position as of Q2 2016 after selling out during the quarter.
  • PNC Financial Services Group sold 344 Intellipharmaceuticals International Inc. shares in Q2 2016, an estimated $7K.
  • PNC Financial Services Group first reported a position in Intellipharmaceuticals International Inc. in Q3 2014 and held it in 2 quarters.
  • PNC Financial Services Group's Intellipharmaceuticals International Inc. position peaked at $36K in Q3 2014.
  • 18 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q2 2016.

Based on PNC Financial Services Group's 13F filing for Q2 2016, filed 5 Aug 2016.